4//SEC Filing
Atchinson Robert 4
Accession 0000902664-25-004455
CIK 0001689548other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:10 PM ET
Size
28.9 KB
Accession
0000902664-25-004455
Insider Transaction Report
Form 4
Adage Capital Management, L.P.
10% Owner
Transactions
- Sale
Common Stock
2025-10-16$104.31/sh+250,000$26,077,375→ 2,081,829 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$91.04/sh+447$40,695→ 2,361,038 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$100.11/sh+559$55,961→ 2,359,116 total(indirect: See footnotes) - Sale
Common Stock, $0.0001 par value per share ("Common Stock")
2025-10-16$90.00/sh+12,600$1,134,032→ 2,361,485 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$131.64/sh+487$64,108→ 2,079,681 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$140.00/sh+19,198$2,687,720→ 2,060,175 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$92.03/sh+1,363$125,441→ 2,359,675 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$132.19/sh+308$40,715→ 2,079,373 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$101.00/sh+27,287$2,755,987→ 2,331,829 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$130.10/sh+1,661$216,090→ 2,080,168 total(indirect: See footnotes)
Atchinson Robert
10% Owner
Transactions
- Sale
Common Stock
2025-10-16$132.19/sh+308$40,715→ 2,079,373 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$140.00/sh+19,198$2,687,720→ 2,060,175 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$91.04/sh+447$40,695→ 2,361,038 total(indirect: See footnotes) - Sale
Common Stock, $0.0001 par value per share ("Common Stock")
2025-10-16$90.00/sh+12,600$1,134,032→ 2,361,485 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$104.31/sh+250,000$26,077,375→ 2,081,829 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$92.03/sh+1,363$125,441→ 2,359,675 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$101.00/sh+27,287$2,755,987→ 2,331,829 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$131.64/sh+487$64,108→ 2,079,681 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$100.11/sh+559$55,961→ 2,359,116 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$130.10/sh+1,661$216,090→ 2,080,168 total(indirect: See footnotes)
Gross Phillip
10% Owner
Transactions
- Sale
Common Stock, $0.0001 par value per share ("Common Stock")
2025-10-16$90.00/sh+12,600$1,134,032→ 2,361,485 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$100.11/sh+559$55,961→ 2,359,116 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$91.04/sh+447$40,695→ 2,361,038 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$92.03/sh+1,363$125,441→ 2,359,675 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$101.00/sh+27,287$2,755,987→ 2,331,829 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$140.00/sh+19,198$2,687,720→ 2,060,175 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$130.10/sh+1,661$216,090→ 2,080,168 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$104.31/sh+250,000$26,077,375→ 2,081,829 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$131.64/sh+487$64,108→ 2,079,681 total(indirect: See footnotes) - Sale
Common Stock
2025-10-16$132.19/sh+308$40,715→ 2,079,373 total(indirect: See footnotes)
Footnotes (11)
- [F1]The securities to which this filing relates are held directly by Adage Capital Partners, L.P., a Delaware limited partnership ("ACP"). Adage Capital Management, L.P., a Delaware limited partnership ("ACM"), serves as the investment manager of ACP and as such has discretion over the portfolio securities held by ACP. Robert Atchinson and Phillip Gross are the managing members of (i) Adage Capital Advisors, L.L.C., a Delaware limited liability company, managing member of Adage Capital Partners GP, L.L.C., a Delaware limited liability company, general partner of ACP and (ii) Adage Capital Partners LLC, a Delaware limited liability company, general partner of ACM.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.0000 to $132.5100, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.0000 to $140.0100, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F2]Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such Reporting Person's pecuniary interest in the securities, if any.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.0000 to $90.5000, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.000 to $91.9900, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.0000 to $92.2500, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.0400 to $100.6500, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.0000 to $104.3869, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.0000 to $130.9700, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.0000 to $131.9800, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Documents
Issuer
Praxis Precision Medicines, Inc.
CIK 0001689548
Entity typeother
Related Parties
1- filerCIK 0001403404
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:10 PM ET
- Size
- 28.9 KB